ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $646,650 | -15.2% | 27,000 | -33.3% | 0.02% | -25.8% |
| Q1 2023 | $762,210 | -33.2% | 40,500 | -49.9% | 0.03% | -44.6% |
| Q2 2022 | $1,141,000 | +214.3% | 80,900 | +439.3% | 0.06% | +229.4% |
| Q1 2022 | $363,000 | +62.8% | 15,000 | +73.5% | 0.02% | +142.9% |
| Q1 2021 | $223,000 | -46.9% | 8,647 | -44.7% | 0.01% | -70.8% |
| Q1 2019 | $420,000 | -90.6% | 15,644 | -94.7% | 0.02% | -89.6% |
| Q2 2018 | $4,471,000 | – | 292,769 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |